Video

Charles Davidson from Northwestern Medicine: SCOUT Trial Looks at New Catheter Therapy Option for Cardiac Patients

Author(s):

As the field of cardiology advances new procedures are being developed to help patients in more effective methods. The SCOUT trial looked at one potential treatment to help patients with tricuspid regurgitation.

As the field of cardiology advances new procedures are being developed to help patients in more effective methods. The SCOUT trial looked at one potential treatment to help patients with tricuspid regurgitation.

Charles Davidson, MD, from Northwestern Medicine discussed the results of the trial during a recent interview with MD Magazine. Davidson said the new technology can be used to help avoid open heart surgery and has also been shown to be more effective that other medical treatment options.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
Orly Vardeny, PharmD | Credit: JACC Journals
© 2024 MJH Life Sciences

All rights reserved.